ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
12.73
-0.37 (-2.82%)
At close: Feb 6, 2026, 4:00 PM EST
13.00
+0.27 (2.12%)
After-hours: Feb 6, 2026, 6:32 PM EST
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $27.4 million as of February 6, 2026. Its market cap has decreased by -9.61% in one year.
Market Cap
27.40M
Enterprise Value
11.97M
1-Year Change
-9.61%
Ranking
Category
Stock Price
$12.73
Market Cap Chart
Since April 16, 2012, ProMIS Neurosciences's market cap has increased from $21.82M to $27.40M, an increase of 25.57%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 27.40M | 86.52% |
| Dec 31, 2025 | 14.69M | -52.59% |
| Dec 31, 2024 | 30.98M | 42.66% |
| Dec 29, 2023 | 21.72M | -41.67% |
| Dec 30, 2022 | 37.23M | -24.28% |
| Dec 31, 2021 | 49.17M | 104.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 30.17M |
| Passage Bio | 29.91M |
| Rein Therapeutics | 29.88M |
| Werewolf Therapeutics | 29.69M |
| TuHURA Biosciences | 29.55M |
| AN2 Therapeutics | 29.05M |
| Lantern Pharma | 28.97M |
| NeuroSense Therapeutics | 28.94M |